CAR‐T therapy as a consolidation in remission B‐ALL patients with poor prognosis

por Yin, Zhichao, Lin, Yuehui, Liu, Dan, Tong, Chunrong, Liu, Shuangyou
Publicado 2022

P387: THE TREATMENT RESPONSE OF A TWO-DOSE REGIMEN OF DOSE-ADJUSTED INOTUZUMAB IN RELAPSED/REFRACTORY B-ALL

por Liu, Shuangyou, An, Lihong, Zhao, Defeng, Hou, Ruifeng, Lin, Yuehui, Guan, Huanhuan, Tong, Chunrong, Wu, Tong
Publicado 2023

Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapy

por Deng, Jingjing, Lin, Yuehui, Zhao, Defeng, Tong, Chunrong, Chang, Alex H., Chen, Wenming, Gao, Wen
Publicado 2022

Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes

por Wang, Fei, Guo, Ye, Chen, Qian, Yang, Zhuo, Ning, Ning, Zhang, Yujuan, Xu, Yonggang, Xu, Xiaodong, Tong, Chunrong, Chai, Li, Cui, Wei
Publicado 2013

Maternal onset de novo SH2D1A mutation and lymphocytic choriomeningitis virus infection in a patient with X-linked lymphoproliferative disease type 1: A case report

por LIU, JINRONG, TIAN, WENJUN, WANG, FANG, TENG, WEN, ZHANG, YANG, TONG, CHUNRONG, ZHANG, CHONGLIN, JU, YING, ZHANG, BINGCHANG, ZHAO, SHUNYING, LIU, HONGXING
Publicado 2015

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

por An, Lihong, Lin, Yuehui, Deng, Biping, Yin, Zhichao, Zhao, Defeng, Ling, Zhuojun, Wu, Tong, Zhao, Yongqiang, Chang, Alex H., Tong, Chunrong, Liu, Shuangyou
Publicado 2022

Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia

por Liu, Shuangyou, Deng, Biping, Yin, Zhichao, Pan, Jing, Lin, Yuehui, Ling, Zhuojun, Wu, Tong, Chen, Dong, Chang, Alex H., Gao, Zhiyong, Song, Yanzhi, Zhao, Yongqiang, Tong, Chunrong
Publicado 2020

Germline cytotoxic lymphocytes defective mutations in Chinese patients with lymphoma

por Chen, Xue, Zhang, Yang, Wang, Fang, Wang, Mangju, Teng, Wen, Lin, Yuehui, Han, Xiangping, Jin, Fangyuan, Xu, Yuanli, Cao, Panxiang, Fang, Jiancheng, Zhu, Ping, Tong, Chunrong, Liu, Hongxing
Publicado 2017

Sequential different B-cell antigen–targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma

por Liu, Ying, Deng, Biping, Hu, Bo, Zhang, Wenqun, Zhu, Qing, Liu, Yang, Wang, Shan, Zhang, Pei, Yang, Ying, Yang, Junhan, Zheng, Qinlong, Yu, Xinjian, Gao, Zifen, Zhou, Chunju, Han, Wei, Yang, Jing, Jin, Ling, Tong, Chunrong, Chang, Alex H., Zhang, Yonghong
Publicado 2022

Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALL

por Deng, Biping, Pan, Jing, Liu, Zhaoli, Liu, Shuangyou, Chen, Yunlong, Qu, Xiaomin, Zhang, Yu'e, Lin, Yuehui, Zhang, Yanlei, Yu, Xinjian, Zhang, Zhongxin, Niu, Xuansha, Luan, Rong, Ma, Ming, Li, Xiaomei, Liu, Tingting, Wu, Xi'ai, Niu, Huan, Chang, Alex H., Tong, Chunrong
Publicado 2021